Whole-genome landscape of pancreatic neuroendocrine tumours

…, M Simbolo, G Butturini, G Van Buren, S Partelli… - Nature, 2017 - nature.com
The diagnosis of pancreatic neuroendocrine tumours (PanNETs) is increasing owing to
more sensitive detection methods, and this increase is creating challenges for clinical …

Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor

R Bettini, S Partelli, L Boninsegna, P Capelli, S Crippa… - Surgery, 2011 - Elsevier
BACKGROUND: Tumor size is a criterion of staging in nonfunctioning pancreatic endocrine
tumors as well as a predictor of outcome after curative resection. This study analyzes the …

Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics

…, P Capelli, GY Lauwers, S Partelli… - Clinical …, 2010 - Elsevier
BACKGROUND & AIMS: Mucin-producing neoplasms (MPNs) of the pancreas include
mucinous cystic neoplasms (MCNs) and main-duct, branch-duct, and combined intraductal …

Middle pancreatectomy: indications, short-and long-term operative outcomes

…, C Bassi, AL Warshaw, M Falconi, S Partelli… - Annals of …, 2007 - journals.lww.com
Objective: To evaluate the indications, perioperative, and long-term outcomes of a large cohort
of patients who underwent middle pancreatectomy (MP). Summary Background Data: MP …

ENETS consensus guidelines for the standards of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours

S Partelli, DK Bartsch, J Capdevila, J Chen… - …, 2017 - karger.com
The small intestine and pancreas are among the most frequent abdominal sites of origin of
neuroendocrine tumours. Distinctive features of these forms are represented by the relatively …

Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors

S Gaujoux, S Partelli, F Maire… - The Journal of …, 2013 - academic.oup.com
Context: Asymptomatic sporadic nonfunctioning, well-differentiated pancreatic neuroendocrine
tumors (NF-PNETs) are increasingly diagnosed, and their management is controversial …

Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term …

…, G Marchegiani, V Rebours, P Levy, S Partelli… - Gut, 2017 - gut.bmj.com
Objective To evaluate mid-term outcomes and predictors of survival in non-operated patients
with pancreatic intraductal papillary mucinous neoplasms (IPMNs) with worrisome features …

Surgical management of insulinomas: short-and long-term outcomes after enucleations and pancreatic resections

…, A Zerbi, L Boninsegna, V Capitanio, S Partelli… - Archives of …, 2012 - jamanetwork.com
… Analysis and interpretation of data: Crippa, Partelli, Balzano, Pederzoli, and Falconi.
Drafting of the manuscript: Crippa, Capitanio, and Partelli. Critical revision of the manuscript for …

Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs)

S Partelli, S Gaujoux, L Boninsegna, R Cherif… - JAMA …, 2013 - jamanetwork.com
Importance Nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) are often indolent
neoplasms without lymph node (LN) metastasis at diagnosis. Therefore, in patients with …

Resectable pancreatic cancer: who really benefits from resection?

G Barugola, S Partelli, S Marcucci, N Sartori… - Annals of surgical …, 2009 - Springer
Background The 1-year disease-related mortality after resection for pancreatic cancer is
approximately 30%. This study examined potential preoperative parameters that would help …